🇺🇸 FDA
Patent

US 7923010

Methods and materials for treating autoimmune diseases and conditions

granted A61KA61K2039/505

Quick answer

US patent 7923010 (Methods and materials for treating autoimmune diseases and conditions) held by The Board of Regents of the University of Texas System expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K2039/505